Early immunomodulator therapy reduces the risk of intestinal resection in Crohns disease: a systematic review and meta-analysis
{{output}}
Background: The optimal timing for initiating immunomodulators (IMs) in Crohns disease (CD) remains unclear. We assessed whether early IM therapy reduces the risk of intestinal resection. ... ...
